Dakota Wealth Management
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1631353
PALM BEACH GARDENS, FL
Position in VRTX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,421,641
+$158,380 QoQ
Shares Held
2,862
+1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#767
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Sep 30, 2022CallValue
$2,895,400
CallShares
10,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Dakota Wealth Management holds $7,339,875 across 7 Biotechnology names. VRTX ranks #3 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
30,200 | $2,625,890 | |
| 2 | EXEL |
Exelixis, Inc.
|
31,025 | $1,688,070 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,862 | $1,421,641 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,466 | $914,109 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
7,592 | $594,225 | |
| 6 | ANVS |
Annovis Bio, Inc.
|
29,000 | $53,940 | |
| 7 | ANIX |
Anixa Biosciences Inc
|
15,000 | $42,000 |
All Filings in VRTX
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,421,641 | 2,862 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $1,263,261 | 2,829 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $1,189,163 | 2,623 | Shares | Defined | 2026-01-13 | |
| 2025-09-30 | $1,010,431 | 2,580 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,340,052 | 3,010 | Shares | Defined | 2025-07-16 | |
| 2025-03-31 | $4,919,468 | 10,147 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $2,983,201 | 7,408 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $15,995,496 | 34,393 | Shares | Defined | 2024-10-23 | |
| 2024-06-30 | $14,226,120 | 30,351 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $13,535,999 | 32,382 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $9,416,248 | 23,142 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $944,113 | 2,715 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $673,203 | 1,913 | Shares | Other | 2023-07-31 | |
| 2023-03-31 | $502,220 | 1,594 | Shares | Other | 2023-04-14 | |
| 2022-12-31 | $531,643 | 1,841 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,895,400 | 10,000 | Call | Sole | 2022-11-10 | |
| 2022-09-30 | $670,574 | 2,316 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $603,594 | 2,142 | Shares | Sole | 2022-08-05 | |
| 2022-06-30 | $5,635,800 | 20,000 | Call | Sole | 2022-08-05 | |
| 2022-03-31 | $595,272 | 2,281 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $439,200 | 2,000 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $362,780 | 2,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $403,260 | 2,000 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $429,780 | 2,000 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $478,115 | 2,023 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $548,321 | 2,015 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $3,351,919 | 11,546 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $475,900 | 2,000 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||